Centogene N.V. (39K.F)

0,3300 -0,0700 (-17,50%) Börsenschluss: 08:05AM CEST

Centogene N.V.

Am Strande 7
Rostock 18055
Germany
49 381 80113 500
https://www.centogene.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 444

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Kim Stratton	CEO & Member of Management Board	861k	N/A	1962
Mr. Jose Miguel Coego Rios	CFO, Legal & IT and Member of Management Board	299k	N/A	N/A
Dr. Peter Bauer M.D.	Chief Medical & Genomic Officer and Member of Management Board	172k	N/A	1970
Dr. Andrin Oswald M.D., Ph.D.	Advisor	871k	N/A	1972
Mr. Ian Rentsch	Chief Commercial Officer & GM of Pharma	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Corporate Governance

Centogene N.V.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 4, Vorstand: 6, Shareholderrechte: 5, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.